Viewing Study NCT06013410



Ignite Creation Date: 2024-05-06 @ 7:27 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06013410
Status: RECRUITING
Last Update Posted: 2023-08-28
First Post: 2023-06-12

Brief Title: Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
Sponsor: Second Affiliated Hospital School of Medicine Zhejiang University
Organization: Second Affiliated Hospital School of Medicine Zhejiang University

Study Overview

Official Title: Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
Status: RECRUITING
Status Verified Date: 2023-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IBS
Brief Summary: The goal of this clinical trial is to explore the pathophysiological effects of the persistently colonized microbiome in irritable bowel syndrome IBS patients The main questions it aims to answer are

Question 1 the microbiome difference of the biofilm between IBS and healthy patients

Question 2 the metabolic product patterns between IBS and healthy patients

Participants will need to take a colonoscopy examination two gut mucosal biopsy samples will be collected during the examination

Researchers will compare the IBS and healthy control groups to see if there was the disease-specific pattern in the microbiome and metabolic product of the biofilm
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None